Creative Biolabs-Immuno-oncology

Anti-GM2 (clone DMF1G0Z.6Z2E.3) SynExpress C-G-ER-X Modified CD8+ T cells (CAT#: ITS-1224-CR1056)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target GM2 (clone DMF1G0Z.6Z2E.3). We employs the Adenovirus (CMV-GFP-ER-XbaI) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
GM2
Clone
DMF1G0Z.6Z2E.3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
ER
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
Adenovirus
Transformation Accuracy
0.97
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.